MiRNA

Study sample collection protocol for analysis by EarlyGuard^TM of serum miRNA from women referred for additional testing due to abnormal breast imaging classified as BI-RADS^® 3, 4 or 5.

Objective

By drawing a tube of blood, data is obtained that will hopefully improve the breast cancer screening process in the future. Researchers are looking at serum miRNA signatures to determine if a subsequent breast biopsy has a higher likelihood of being positive or negative. This study is recruiting patients who have breast imaging studies suspicious for cancer discovered during screening.

Principal Investigator

• Steven Scallon, MD

Contact

• Michael Bowie, DO, CCRP
  michael.bowie@overlakehospital.org
  Phone: (425) 635-6082
• Katia Soleil
  katia.soleil@overlakehospital.org
  Phone: (425) 467-3696

Location

Overlake Medical Center
1035 116th Ave NE 
Bellevue, WA 98004

Phone: (425) 688-5000